Guidance

MMR: patient group direction (PGD) template

PGD template to support the national MMR vaccination programme.

• From: UK Health Security Agency
• Published: 24 March 2016
• Last updated: 30 January 2024 — See all updates

Applies to England

Documents

MMR: patient group direction (PGD) template

Ref: UKHSA gateway number: GOV-15882

MS Word Document, 176 KB

This file may not be suitable for users of assistive technology.

Request an accessible format.

If you use assistive technology (such as a screen reader) and need a version of this document in a more accessible format, please email publications@ukhsa.gov.uk. Please tell us what format you need. It will help us if you say what assistive technology you use.

Details

This patient group direction (PGD) template supports the administration of measles, mumps and rubella (MMR) vaccine, to individuals from 1 year of age for routine immunisation or from 6 months of age if early protection is required, in accordance with the national immunisation programme and the UK Health Security Agency (UKHSA) guidelines on post-exposure prophylaxis for measles.

MMR vaccine PGD version 5.00 is valid from 29 February 2024 to 31 January 2027.

Practitioners must not use this PGD template until it has been authorised in Section 2. This is a legal requirement (see Human Medicines Regulations 2012). Practitioners should follow local policy and procedures to access authorised PGD documents.

This PGD template should be used with reference to current national guidance, the Green Book, and Summary of Product Characteristics for the vaccine.

Published 24 March 2016
Last updated 30 January 2024 + show all updates

1. 30 January 2024

   Added version 5, see page 2 for change history.

2. 21 February 2022

   Added version 4 (see page 2 for change history).

3. 28 January 2020

   Added V03.00 - routine review.

4. 21 February 2018

   Routine PGD update on expiry of v01.00.

5. 24 March 2016

   First published.